Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04746612
Title A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH30134 in Patients With Advanced Solid Tumours
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Haihe Biopharma Co., Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
Blacktown Hospital Blacktown Australia Details
Scientia Clinical Research Randwick Australia Details
Sun Yat-sen University Cancer Center Guangzhou China Details
Fudan University Zhongshan Hospital Shanghai China Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field